ClinicalTrials.Veeva

Menu

Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used. (VECUVG)

T

Toulouse University Hospital

Status

Withdrawn

Conditions

Voluntary Termination of Pregnancy

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06140069
RC31/23/0563

Details and patient eligibility

About

Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. 2022-295) extended the legal deadline for voluntary termination of pregnancy from 14 to 16 weeks of amenorrhea (SA). The recommendations have not been updated following this legal extension, the centers performing abortions are therefore free regarding the protocol for carrying out these so-called late abortions (between 14 and 16 weeks). There are two pregnancy termination techniques practiced in France: medical or surgical. The drug method consists of drug-induced expulsion of the pregnancy. This method is carried out in the delivery room, and lasts several hours. The surgical method consists of an endouterine aspiration carried out in the operating room, which lasts approximately 30 minutes. At the Toulouse University Hospital, as in many centers in France, it is the patient who chooses the method, apart from a contraindication to one or other of these methods. Due to the recent nature of these late abortions, practitioners still have little experience of the consequences of these procedures and this compromises the quality of the information provided to patients. It is necessary to have quality studies to improve knowledge about late abortions, in order to be able to correctly inform patients and allow them to make an informed choice regarding the method used.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any adult patient
  • Having given her non-opposition after clear and fair information (patient who understands and reads French)
  • Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound)
  • Singleton pregnancy
  • Progressive pregnancy

Exclusion criteria

  • Protected adult patient (guardianship, curatorship, protection of justice)
  • Developing psychiatric pathologies
  • Fetal anomaly detected

Trial design

0 participants in 1 patient group

Experimental: Patient treated at the Toulouse University Hospital for an abortion
Description:
Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound) presenting with a single and evolving pregnancy.
Treatment:
Other: Questionnaire

Trial contacts and locations

0

Loading...

Central trial contact

Caroline Peyrot, CRA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems